Evidence map›Paper›PMID 28559329›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Antimalarials inhibit hematin crystallization by unique drug-surface site interactions.

Katy N Olafson, Tam Q Nguyen, Jeffrey D Rimer, Peter G Vekilov

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 137 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Development of convenient crystallization inhibition assays for structure-activity relationship studies in the discovery of crystallization inhibitors.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2023
    Article
  19. A Nanoparticle-Based Model System for the Study of Heterogeneous Nucleation Phenomena.Langmuir : the ACS journal of surfaces and colloids · 2023
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Katy N OlafsonDepartment of Chemical and Biomolecular Engineering, University of Houston, Houston, TX 77204-4004.
Tam Q NguyenDepartment of Chemical and Biomolecular Engineering, University of Houston, Houston, TX 77204-4004.
Jeffrey D RimerDepartment of Chemical and Biomolecular Engineering, University of Houston, Houston, TX 77204-4004; jrimer@central.uh.edu vekilov@uh.edu.
Peter G VekilovDepartment of Chemical and Biomolecular Engineering, University of Houston, Houston, TX 77204-4004; jrimer@central.uh.edu vekilov@uh.edu.
University of Houston · US

Funding

Nanobiology Interdisciplinary Graduate Training ProgramT32EB009379 · NIBIB · RICE UNIVERSITY · PI DREZEK, REBEKAH A. · 2009 to 2013
$1.6M
Hematin crystallization in Plasmodium parasitesR21AI126215 · NIAID · UNIVERSITY OF HOUSTON · PI VEKILOV, PETER G · 2016 to 2017
$383k
NIAID NIH HHS R21 AI126215NIBIB NIH HHS T32 EB009379
6 · The paper itself

Abstract

In malaria pathophysiology, divergent hypotheses on the inhibition of hematin crystallization posit that drugs act either by the sequestration of soluble hematin or their interaction with crystal surfaces. We use physiologically relevant, time-resolved in situ surface observations and show that quinoline antimalarials inhibit β-hematin crystal surfaces by three distinct modes of action: step pinning, kink blocking, and step bunch induction. Detailed experimental evidence of kink blocking validates classical theory and demonstrates that this mechanism is not the most effective inhibition pathway. Quinolines also form various complexes with soluble hematin, but complexation is insufficient to suppress heme detoxification and is a poor indicator of drug specificity. Collectively, our findings reveal the significance of drug-crystal interactions and open avenues for rationally designing antimalarial compounds.

Indexed as

AdsorptionAntimalarialsBinding SitesChloroquineCrystallizationCrystallography, X-RayDrug Evaluation, PreclinicalHemeHemeproteinsHeminPlasmodium falciparumQuinolinesAntimalarialsChloroquineHemeHemeproteinsHeminhemozoinQuinolinescrystallization inhibitionhematin crystalsheme detoxificationmalariaP. falciparum

Identifiers

PMID28559329
PMCPMC5530657
OpenAlexW2619398250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.